ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726767; 2) Community: the network communities that were significantly associated with the response to NSC 726767; 3) Molecule: the relationships between components within communities and NSC 726767; 4) MDR: the compounds that were significantly associated with the NSC 726767.

NSC Compound Enrichment Correlation
NSC 38086 Null 0.0312262198176283 0.097117956
NSC 53327 Null 0.0312262198176283 0.22539595
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0312262198176283 0.63229665
NSC 610459 Camptothecin Derivative 0.0312262198176283 0.38214825
NSC 621322 Null 0.0312262198176283 0.055006815
NSC 625505 Null 0.0312262198176283 0.26012309
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0312262198176283 0.6665389
NSC 631391 7H-Pyrido[4,3-c]carbazole-6-methanol,methylcarbamate (ester) (9CI) 0.0312262198176283 0.43400591
NSC 639186 Raltitrexed 0.0312262198176283 0.49435075
NSC 645813 Null 0.0312262198176283 0.69837253
Total:127  Current:90    [First] [Prev] [Next] [Last]